Showing papers for search query "FDA+Requirement"+"Medical"+"Regulated+Environment"

     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Development of a Fully Integrated Global Learning System in a Regulated Environment
     Author ['C Sigmund', 'D Wallace', 'T Kliever']
     Venue European Conference on e …
     Year 2013
     Abstract Conducting training in a regulated environment requires additional levels of security, tracking, and reporting not  Federal Regulations (CFR) Title 21, Part 11, requires that all medical product manufacturers  to create and validate-well in excess of the one-hour FDA requirement
     Url http://search.proquest.com/openview/2616f896b4618dbacdbc8b7d87454d3b/1?pq-origsite=gscholar&cbl=1796419


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future
     Author ['AC Segreti', 'HM Leung', 'GG Koch', 'RL Davis']
     Venue Journal of …
     Year 2001
     Abstract BIOPHARMACEUTICAL STATISTICS IN A PHARMACEUTICAL REGULATED ENVIRONMENT: PAST, PRESENT, AND FUTURE  Gradually, an FDA requirement appeared for at least two independent positive  two groups, each serving three different medical divisions within the
     Url https://www.tandfonline.com/doi/abs/10.1081/BIP-120008853


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Model‐Based Systems Engineering as an Enabler for Regulatory Design Compliance
     Author ['J Dean', 'C Henderson', 'J Gardner']
     Venue INCOSE International …
     Year 2012
     Abstract engineering is being used on this project due to the FDA regulated environment, although the  The Food and Drug Administration details good manufacturing practice for medical devices in Title 21  Table 1: FDA Process Records FDA$Requirement$ Process$Record/Deliverable
     Url https://onlinelibrary.wiley.com/doi/abs/10.1002/j.2334-5837.2012.tb01473.x


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Cost-contained regulatory compliance: for the pharmaceutical, biologics, and medical device industries
     Author ['S Weinberg']
     Venue NA
     Year 2011
     Abstract Page 1. Cost-Contained Regulatory Compliance for rhe Pharmaceutical, Biologies, and Medical Device Industries SANDY WEINBERG ®WILEY Page 2  p. ; cm. ISBN 978-0-470-55235-3 (cloth) 1. Medical instruments and apparatus industry–United States–Cost control
     Url https://books.google.com/books?hl=en&lr=&id=qAZri2M0yTEC&oi=fnd&pg=PR1&dq=%22FDA+Requirement%22+%22Medical%22+%22Regulated+Environment%22&ots=Eccixqdq4q&sig=B-721cGOShNGAmwgKve4M50z9I8


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Dynamic Incentives: Improving the Safety, Effectively, and Availability of Medical Products through Progressively Increasing Damage Caps for Manufacturers
     Author ['SS Evans']
     Venue U. Ill. L. Rev.
     Year 2007
     Abstract Page 1. DYNAMIC INCENTIVES: IMPROVING THE SAFETY, EFFECTIVITY, AND AVAILABILITY OF MEDICAL PRODUCTS THROUGH PROGRESSIVELY INCREASING DAMAGE CAPS FOR MANUFACTURERS SCOTTS  Medical Device Amendments of 1976, Pub. L. No
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/unilllr2007&section=38


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title 21 CFR part 11: Complete guide to international computer validation compliance for the pharmaceutical industry
     Author ['O López']
     Venue NA
     Year 2004
     Abstract Specifically for medical devices, books on software reliability tend to set aside the user interface issue, and treat it as the sole province of  the required information, or be directly able to examine the product in close detail, before it is transferred to the regulated environment sector
     Url https://books.google.com/books?hl=en&lr=&id=X3qmDwAAQBAJ&oi=fnd&pg=PP1&dq=%22FDA+Requirement%22+%22Medical%22+%22Regulated+Environment%22&ots=DZ3-4h3aID&sig=iX0cn4n-_LLGNqiHcTrKJHWCAjE


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Evaluating Twitter as a complementary data source for pharmacovigilance
     Author ['J Lardon', 'F Bellet', 'R Aboukhamis', 'H Asfari']
     Venue Expert opinion on …
     Year 2018
     Abstract In a recent systematic review based on 51 studies assessing over 174 different social media sites, the overall prevalence of adverse events (officially defined as an untoward medical occurrence temporally associated with the use of a drug, but not necessary causally related to
     Url https://www.tandfonline.com/doi/abs/10.1080/14740338.2018.1499724


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Pharmaceutical efficacy: the illusory legal standard
     Author ['JJ Darrow']
     Venue Wash. & Lee L. Rev.
     Year 2013
     Abstract Rather than specifying a fixed level of * The author is a Research Fellow at Harvard Medical School, a Postdoctoral Research Fellow in the Division of Pharmacoepidemiology and Pharmacoeconomics (Program On Regulation, Therapeutics And Law (PORTAL)) at Brigham
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/waslee70&section=51


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title Developing a measurement system for the pharmaceutical compliance process using the Balanced Scorecard
     Author ['G Bader']
     Venue NA
     Year 2007
     Abstract that oversees compliance; FDA is the government agency responsible for regulating food, dietary supplements, drugs, cosmetics, medical devices, and  Another paper that ponders the issue of a Balanced Scorecard in a regulated environment is Balancing the Scorecard: Key
     Url http://search.proquest.com/openview/5c32007f93951f8b9bf00e33810c1968/1?pq-origsite=gscholar&cbl=18750&diss=y


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title The Impact of Total Quality Performance on Compliance
     Author ['C Medina']
     Venue DRUGS AND THE PHARMACEUTICAL SCIENCES
     Year 2004
     Abstract For example, if the records are not owned by the inves- tigator or under his or her control, such as patient medical records held by  Trending of nonreportable events can prove to be very valuable during phase IV postmarketing studies, although this is not an FDA requirement
     Url http://ndl.ethernet.edu.et/bitstream/123456789/502/1/34.pdf#page=510


     Search term "FDA+Requirement"+"Medical"+"Regulated+Environment"
     Title The application of dried blood spots in toxicokinetic and pharmacokinetic studies
     Author ['M Barfield']
     Venue NA
     Year 2017
     Abstract Page 1. The Application of Dried Blood Spots in Toxicokinetic and Pharmacokinetic Studies M Barfield Doctor of Philosophy 2017 Page 2. i The Application of Dried Blood Spots in Toxicokinetic and Pharmacokinetic Studies Matthew Barfield
     Url http://eprints.lincoln.ac.uk/30876/1/30876%20Barfield%20Matt%20Chemistry%20Septemer%202017.pdf

